Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Spelman T, Kalincik T, Jokubaitis V, Zhang A, Pellegrini F, Wiendl H, Belachew S, Hyde R, Verheul F, Lugaresi A, et al. Neurol Clin Pract. 2016 Apr; 6(2):102-115. PMID: 27104064. Abstract CommentRecommendBookmarkWatch